Imricor Medical Systems Secures AU$60 Million in Institutional Placement

MT Newswires Live

05/04

Imricor Medical Systems (ASX:IMR) has secured firm commitments from new and existing institutional and sophisticated investors to raise AU$60 million through the issue of 32.4 million Chess depositary interests (CDI) at AU$1.85 per CDI, reflecting a 7.7% discount to its 10-day volume-weighted average price, according to a Monday Australian bourse filing.

The new CDIs will be issued in a single tranche under the company's existing placement capacity and will rank equally with existing CDIs, per the filing.

Settlement is expected on Thursday, with the new CDIs scheduled for issuance and set to begin trading on the Australian Securities Exchange on Friday, the filing said.

The funds will be used to accelerate the company's growth strategy, including launching NorthStar in the US, advancing regulatory approvals for its full electrophysiology platform, completing key clinical programs, progressing pulsed field ablation development, and supporting expansion in the Middle East and other target markets, the filing added.

The company's shares fell 1% in recent Monday trade.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2632598487"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2632598487\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2632598487?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 09:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2632598487","market":"sh","top_or_hot":-1,"title":"Imricor Medical Systems Secures AU$60 Million in Institutional Placement","media":"MT Newswires Live","content":"<html><body><p> Imricor Medical Systems (ASX:IMR) has secured firm commitments from new and existing institutional and sophisticated investors to raise AU$60 million through the issue of 32.4 million Chess depositary interests (CDI) at AU$1.85 per CDI, reflecting a 7.7% discount to its 10-day volume-weighted average price, according to a Monday Australian bourse filing.</p><p>The new CDIs will be issued in a single tranche under the company's existing placement capacity and will rank equally with existing CDIs, per the filing.</p><p>Settlement is expected on Thursday, with the new CDIs scheduled for issuance and set to begin trading on the Australian Securities Exchange on Friday, the filing said.</p><p>The funds will be used to accelerate the company's growth strategy, including launching NorthStar in the US, advancing regulatory approvals for its full electrophysiology platform, completing key clinical programs, progressing pulsed field ablation development, and supporting expansion in the Middle East and other target markets, the filing added.</p><p>The company's shares fell 1% in recent Monday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Imricor Medical Systems Secures AU$60 Million in Institutional Placement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImricor Medical Systems Secures AU$60 Million in Institutional Placement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-05-04 09:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Imricor Medical Systems (ASX:IMR) has secured firm commitments from new and existing institutional and sophisticated investors to raise AU$60 million through the issue of 32.4 million Chess depositary interests (CDI) at AU$1.85 per CDI, reflecting a 7.7% discount to its 10-day volume-weighted average price, according to a Monday Australian bourse filing.</p><p>The new CDIs will be issued in a single tranche under the company's existing placement capacity and will rank equally with existing CDIs, per the filing.</p><p>Settlement is expected on Thursday, with the new CDIs scheduled for issuance and set to begin trading on the Australian Securities Exchange on Friday, the filing said.</p><p>The funds will be used to accelerate the company's growth strategy, including launching NorthStar in the US, advancing regulatory approvals for its full electrophysiology platform, completing key clinical programs, progressing pulsed field ablation development, and supporting expansion in the Middle East and other target markets, the filing added.</p><p>The company's shares fell 1% in recent Monday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IMR.AU","symbol_name":"IMRICOR MEDICAL SYSTEMS-CDI","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2632598487","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2632598487","pubTimestamp":1777857871,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Imricor Medical Systems  has secured firm commitments from new and existing institutional and sophisticated investors to raise AU$60 million through the issue of 32.4 million Chess depositary interests  at AU$1.85 per CDI, reflecting a 7.7% discount to its 10-day volume-weighted average price, according to a Monday Australian bourse filing.The new CDIs will be issued in a single tranche under the company's existing placement capacity and will rank equally with existing CDIs, per the filing.Settlement is expected on Thursday, with the new CDIs scheduled for issuance and set to begin trading on the Australian Securities Exchange on Friday, the filing said.The funds will be used to accelerate the company's growth strategy, including launching NorthStar in the US, advancing regulatory approvals for its full electrophysiology platform, completing key clinical programs, progressing pulsed field ablation development, and supporting expansion in the Middle East and other target markets, the fi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IMR.AU":"IMRICOR MEDICAL SYSTEMS-CDI","BK7503":"科技股","BK7007":"医疗保健设备","BK7508":"医药生物股"},"translate_title":"Imricor Medical Systems获得6000万澳元机构配售","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IMR.AU":1},"content_text":"Imricor Medical Systems (ASX:IMR) has secured firm commitments from new and existing institutional and sophisticated investors to raise AU$60 million through the issue of 32.4 million Chess depositary interests (CDI) at AU$1.85 per CDI, reflecting a 7.7% discount to its 10-day volume-weighted average price, according to a Monday Australian bourse filing.The new CDIs will be issued in a single tranche under the company's existing placement capacity and will rank equally with existing CDIs, per the filing.Settlement is expected on Thursday, with the new CDIs scheduled for issuance and set to begin trading on the Australian Securities Exchange on Friday, the filing said.The funds will be used to accelerate the company's growth strategy, including launching NorthStar in the US, advancing regulatory approvals for its full electrophysiology platform, completing key clinical programs, progressing pulsed field ablation development, and supporting expansion in the Middle East and other target markets, the filing added.The company's shares fell 1% in recent Monday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}